Currently I am involved in a large screening project involving young Air Force Recruits at Lackland Air Force Base. I am collecting plasma to be tested for levels of protein C, protein S, artithrombin III and Activated Protein C Resistance. This project is designed to determine the prevalence of deficiencies of these proteins as well as the significance of them. I am also interested in developing support care and treatment protocols for patients undergoing autologous bone marrow transplants. This coming year we will be involved with an international trial of low molecular weight heparin to prevent venoocclusive disease of the liver.

Callander N, Rapaport SI. Trousseau's syndrome. West J Medicine, l993, l58(4):364-37l.

Callander NS, Varke N, Rao LVM. Immunohistochemical identification of tissue factor in solid tumors. Cancer, l992, 70(5):ll94-200l.

Callander N, Rao LVM, Nordfang O, Sandset PM, Norn-Cramen B, Rapaport SI. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces: evidence that REPI can bind to and inhibit factor Vlla/TF complexes in the absence of factor Xa. J. Biological Chemistry, l992, 267(2):876-82.

Essell JH, Thompson, JM, Harman GS, Halvorson RD, Snyder MJ, Callander NS, Clement DJ. Pilot trial of prophylactic ursodiaol to decrease the incidence of veno occlusive disease of the liver in allogeneic bone marrow transplant patients. Bone Marrow Transplantation, l992, l0(4):367-72.

bone marrow transplantation, coagulation